Health and Medicine
Nov. 9, 2020—Yi Ren, assistant professor of biochemistry, has contributed to research on the function and impact of the SARS-CoV-2 protein on immune signaling protein in host cells. This understanding may lead to the development of immune-enhancing therapeutics.
Nov. 6, 2020—Assistant Professor of Biochemistry Yi Ren and her team have made several discoveries to illuminate the mechanisms of key host-pathogen interactions involving viruses, with implications for gaining a better understanding of SARS-CoV-2, the virus that causes COVID-19.
Nancy Carrasco’s pioneering public health work recognized with National Academy of Medicine election
Nov. 4, 2020—Nancy Carrasco, professor and chair of the Department of Molecular Physiology and Biophysics and the Joe C. Davis Chair of Biomedical Science, receives one of the highest honors in health and medicine.
Velma McBride Murry’s pathbreaking family intervention work recognized with National Academy of Medicine election
Nov. 4, 2020—Velma McBride Murry, University Professor of Health Policy and Human & Organizational Development, receives one of the highest honors in health and medicine.
Spontaneous release of neurotransmitters in the brain identified as a culprit of developmental disorders in infants and children
Nov. 3, 2020—Vanderbilt researchers discover how a group of neurodevelopmental disorders ranging in severity are caused in infants and children, opening new avenues for therapeutics.
Jerri Rook is awarded the Alzheimer’s Drug Discovery Foundation’s prestigious Melvin R. Goodes prize
Nov. 2, 2020—Behavioral and systems neuropharmacologist Jerri Rook is recognized by the Alzheimer’s Drug Discovery Foundation with the Goodes Prize to continue her work in Alzheimer’s disease research.
Vanderbilt University anti-inflammatory therapy licensed to Amytrx is now in clinical trials for eczema treatment
Oct. 27, 2020—Jacek Hawiger’s anti-inflammatory peptide therapy, licensed by Amytrx and now in clinical trials, has the potential to safely and effectively treat a multitude of inflammatory and metabolic diseases.
Oct. 27, 2020—Vanderbilt researchers—including Charles Sanders, associate dean for research and professor of biochemistry, and graduate student Justin Marinko—have illuminated the cause of Charcot-Marie-Tooth disease, putting them on the road to developing therapeutic approaches for the disease that affects one in 2,500 people.
Oct. 21, 2020—Vanderbilt University School of Nursing will use a $3.2 million federal grant for a scholarship program for economically disadvantaged students from underrepresented racial and ethnic minority backgrounds. The program aims to increase diversity in primary health care providers, particularly in medically underserved areas.
Interdisciplinary melanoma research brings understanding of cellular resistance to cancer treatment, opening doors to new cures
Oct. 21, 2020—Drug-tolerant persister cells–those that survive cancer treatment–found to rely on similar survival mechanisms across cancers, in a groundbreaking study led by Vanderbilt researchers.
Oct. 20, 2020—Craig Lindsley, the William K. Warren, Jr. Chair and University Professor of Pharmacology, Biochemistry and Chemistry, will become director of Vanderbilt University’s Warren Center for Neuroscience Drug Discovery, effective Dec. 1, 2020.
Oct. 20, 2020—Three Vanderbilt faculty members—Nancy Carrasco, Velma McBride Murry and Consuelo Wilkins—have been elected this year to the National Academy of Medicine, the organization announced on Monday.